237 related articles for article (PubMed ID: 22585382)
1. The effects of Photofrin-mediated photodynamic therapy on the modulation of EGFR in esophageal squamous cell carcinoma cells.
Yang PW; Hung MC; Hsieh CY; Tung EC; Wang YH; Tsai JC; Lee JM
Lasers Med Sci; 2013 Feb; 28(2):605-14. PubMed ID: 22585382
[TBL] [Abstract][Full Text] [Related]
2. The effect of ephrin-A1 on resistance to Photofrin-mediated photodynamic therapy in esophageal squamous cell carcinoma cells.
Yang PW; Chiang TH; Hsieh CY; Huang YC; Wong LF; Hung MC; Tsai JC; Lee JM
Lasers Med Sci; 2015 Dec; 30(9):2353-61. PubMed ID: 26450615
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Study of Antineoplastic Sinoporphyrin Sodium-PDT via In Vitro and In Vivo Models.
Shi R; Li C; Jiang Z; Li W; Wang A; Wei J
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085075
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of photodynamic therapy for lung cancers.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Maehara S; Imai K; Shima K; Ohira T; Kato H; Ikeda N
Lasers Surg Med; 2011 Sep; 43(7):591-9. PubMed ID: 22057486
[TBL] [Abstract][Full Text] [Related]
5. Changes in intracellular Ca2+ concentrations related to PDT-induced apoptosis in photosensitized human cancer cells.
Tajiri H; Hayakawa A; Matsumoto Y; Yokoyama I; Yoshida S
Cancer Lett; 1998 Jun; 128(2):205-10. PubMed ID: 9683284
[TBL] [Abstract][Full Text] [Related]
6. Treatment outcome of Photofrin-based photodynamic therapy for T1 and T2 oral squamous cell carcinoma and dysplasia.
Ikeda H; Tobita T; Ohba S; Uehara M; Asahina I
Photodiagnosis Photodyn Ther; 2013 Sep; 10(3):229-35. PubMed ID: 23993848
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer resistant protein (BCRP) is a molecular determinant of the outcome of photodynamic therapy (PDT) for centrally located early lung cancer.
Usuda J; Tsunoda Y; Ichinose S; Ishizumi T; Ohtani K; Maehara S; Ono S; Tsutsui H; Ohira T; Okunaka T; Furukawa K; Sugimoto Y; Kato H; Ikeda N
Lung Cancer; 2010 Feb; 67(2):198-204. PubMed ID: 19477032
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy downregulates the function of regulatory T cells in patients with esophageal squamous cell carcinoma.
Reginato E; Lindenmann J; Langner C; Schweintzger N; Bambach I; Smolle-Jüttner F; Wolf P
Photochem Photobiol Sci; 2014 Sep; 13(9):1281-9. PubMed ID: 25005268
[TBL] [Abstract][Full Text] [Related]
9. Salvage photodynamic therapy for local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
Hatogai K; Yano T; Kojima T; Onozawa M; Daiko H; Nomura S; Yoda Y; Doi T; Kaneko K; Ohtsu A
Gastrointest Endosc; 2016 Jun; 83(6):1130-1139.e3. PubMed ID: 26608125
[TBL] [Abstract][Full Text] [Related]
10. Specific cellular accumulation of photofrin-II in EC cells promotes photodynamic treatment efficacy in esophageal cancer.
Gao S; Liang S; Ding K; Qu Z; Wang Y; Feng X
Photodiagnosis Photodyn Ther; 2016 Jun; 14():27-33. PubMed ID: 26829562
[TBL] [Abstract][Full Text] [Related]
11. Influence and mechanism of 5-aminolevulinic acid-photodynamic therapy on the metastasis of esophageal carcinoma.
Zhang X; Cai L; He J; Li X; Li L; Chen X; Lan P
Photodiagnosis Photodyn Ther; 2017 Dec; 20():78-85. PubMed ID: 28811223
[TBL] [Abstract][Full Text] [Related]
12. Subcellular localization of Photofrin determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: when plasma membranes are the main targets.
Hsieh YJ; Wu CC; Chang CJ; Yu JS
J Cell Physiol; 2003 Mar; 194(3):363-75. PubMed ID: 12548556
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.
Domagala A; Stachura J; Gabrysiak M; Muchowicz A; Zagozdzon R; Golab J; Firczuk M
BMC Cancer; 2018 Feb; 18(1):210. PubMed ID: 29463237
[TBL] [Abstract][Full Text] [Related]
14. Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3.
Hsieh YJ; Chien KY; Lin SY; Sabu S; Hsu RM; Chi LM; Lyu PC; Yu JS
Cell Death Dis; 2012 Jul; 3(7):e347. PubMed ID: 22785533
[TBL] [Abstract][Full Text] [Related]
15. Effects of photodynamic therapy on adhesion molecules and metastasis.
Rousset N; Vonarx V; Eléouet S; Carré J; Kerninon E; Lajat Y; Patrice T
J Photochem Photobiol B; 1999; 52(1-3):65-73. PubMed ID: 10643074
[TBL] [Abstract][Full Text] [Related]
16. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
[TBL] [Abstract][Full Text] [Related]
18. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.
Grosjean P; Wagnieres G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1998 Jun; 77(11):1989-95. PubMed ID: 9667680
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of Candida albicans germ tubes and biofilms to photofrin-mediated phototoxicity.
Chabrier-Roselló Y; Foster TH; Pérez-Nazario N; Mitra S; Haidaris CG
Antimicrob Agents Chemother; 2005 Oct; 49(10):4288-95. PubMed ID: 16189110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
